Caspase-8 activation independent of CD95/CD95-L interaction during paclitaxel-induced apoptosis in human colon cancer cells (HT29-D4)

Biochemical Pharmacology

Volumn 60, Issue 11, 2000, Pages 1579-1584

  Gonçalves, Anthony ^a   Braguer, Diane ^a   Carles, Gérard ^a   André, Nicolas ^a   Prevôt, Charles ^a   Briand, Claudette ^a  

^a CNRS   (France)

Author keywords

Antimicrotubule agents; Apoptosis; Caspase 8; CD95; Paclitaxel

Indexed keywords

ANTIMITOTIC AGENT; CASPASE 8; DOCETAXEL; FAS ANTIGEN; PACLITAXEL; VINCA ALKALOID;

APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ASSAY; HUMAN; HUMAN CELL; IMMUNOBLAST; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION;

ANTIGENS, CD95; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-X PROTEIN; CASPASE 8; CASPASE 9; CASPASES; COLONIC NEOPLASMS; ENZYME ACTIVATION; FAS LIGAND PROTEIN; HT29 CELLS; HUMANS; MEMBRANE GLYCOPROTEINS; MITOCHONDRIA; MITOSIS; PACLITAXEL; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0034575597     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00481-0     Document Type: Article

References (35)

1. The taxoids. Comparative clinical pharmacology and therapeutic potential
2. Microtubules and actin filaments: Dynamic targets for cancer chemotherapy
3. Taxol-induced bcl-2 phosphorylation and death of prostate cancer cells
4. Mechanism of action of taxanes in prostate cancer
5. Molecular effects of paclitaxel: Myths and reality
6. The Bcl-2 protein family: Arbiters of cell survival
7. Caspases: Enemies within
8. Bcl-X(L) overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL60 cells
9. Temporal relationship of CDK1 activation and mitotic arrest to cytosolic accumulation of cytochrome C and caspase-3 activity during Taxol-induced apoptosis of human AML HL-60 cells
10. Paclitaxel-associated multinucleation is permitted by the inhibition of caspase activation: A potential early step in drug resistance
11. FLICE is activated by association with the CD95 death-inducing signaling complex
12. The CD95 (Apo-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells
13. Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells
14. Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs
15. Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction
16. Drug-induced apoptosis in lung cancer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway
17. The effect of combining antitubulin agents on differentiated and undifferentiated human colon cancer cells
18. FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b
19. IFN-γ induces cell growth inhibition by Fas-mediated apoptosis: Requirement of STAT1 protein for up-regulation of Fas and FasL expression
20. Spontaneous and induced dome formation by two clonal cell populations derived from a human adenocarcinoma cell line, HT29
21. Differentiation of human colon cancer cells changes the expression of β-tubulin isotypes and MAPs
22. Comparative effects of taxol and Taxotere on two different human carcinoma cell lines
23. Tau protein is involved in the apoptotic process induced by antitubulin agents on neuroblastoma cells
24. Bcl-x(L) is phosphorylated in malignant cells following microtubule disruption
25. Caspase-8 mediates caspase-3 activation and cytochrome c release during singlet oxygen-induced apoptosis of HL-60 cells
26. Mitochondrial control of nuclear apoptosis
27. Expression, purification, crystallization, and biochemical characterization of a recombinant protein phosphatase
28. Divergent induction of apoptosis and IL-8 secretion in HT29 cells in response to TNF-α and ligation of Fas antigen
29. Loss of the Bcl-2 phosphorylation loop domain increases resistance of human leukemia cells (U937) to paclitaxel-mediated mitochondrial dysfunction and apoptosis
30. Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis
31. Differential regulation and ATP requirement for caspase-8 and caspase-3 activation during CD95- and anticancer drug-induced apoptosis
32. Paclitaxel induces apoptosis in Saos-2 cells with CD95L upregulation and Bcl-2 phosphorylation
33. Bcl-2-mediated drug resistance: Inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription
34. Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis
35. Functional consequences of the sustained or transient activation by Bax of the mitochondrial permeability transition pore